SCHEMBL4186546

SCHEMBL4186546

CC(CC1CCCCC1)NCc1cnccc1OC(=O)Nc1cc2ccccc2s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 1/20 0.36
F12 P00748 1/20 0.36
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
OPRM1 P35372 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC2 Q92769 1/20 0.33
GAA P10253 1/20 0.33
SYK P43405 1/20 0.32
AURKB Q96GD4 1/20 0.32
CNR1 P21554 3/20 0.32
METAP2 P50579 2/20 0.32
METAP1 P53582 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197246 0.94 REN (0.36) RENF12HTR1ADRD2HTR2A
SCHEMBL4197712 0.92 NAMPT (0.36) RENHTR1ADRD2HTR2AKDM4C
Cyclohexane SCHEMBL4194020 0.89 KDM4C (0.38) OPRM1KDM4CHDAC2FPR1FPR2
SCHEMBL4190982 0.87 HTR1A (0.36) HTR1ADRD2HTR2AOPRM1MEN1
SCHEMBL4190568 0.85 GCK (0.37) RENF12HTR1ADRD2HTR2A
SCHEMBL4201892 0.85 REN (0.38) RENF12HTR1ADRD2HTR2A
SCHEMBL4708832 0.85 KDM4C (0.38) RENF12OPRM1KDM4CMEN1
SCHEMBL4194935 0.85 REN (0.35) RENHTR1ADRD2HTR2AOPRM1
SCHEMBL4706558 0.84 OPRM1 (0.39) RENF12HTR1ADRD2HTR2A
SCHEMBL4195445 0.84 REN (0.38) RENHTR1ADRD2HTR2AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 REN 4111/4885F12 3757/4885HTR1A 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.